C-reactive protein as a potential biomarker of effectiveness of avelumab plus axitinib in people with advanced kidney cancer
A biomarker is a biological molecule found in blood, other body [...]
A biomarker is a biological molecule found in blood, other body [...]
Health and Social Care Secretary and Deputy Prime Minister, Thérèse [...]
Late last week we learnt that the National Institute for [...]
Cell metabolism in kidney cancer tumours is disrupted, and tumour [...]
The phase 2 KEYNOTE-B61 study was presented at the recent [...]
Results from the phase 3 CLEAR studywere presented at the [...]
The National Core Studies Immunity (NCSi) Programme and UK Coronavirus Immunology Consortium (UK-CIC) are [...]
The results from the IMmotion010 study were presented at the [...]
In this phase 3 randomised study, presented at the European [...]
The results of COSMIC-131 were presented at the European Society [...]